Integrative Systems Biology and Experimental Validation Unveil GALNT14 as a Novel Diagnostic Biomarker and Therapeutic Target for Sepsis.

Hum Mutat · 2026 · PMC13171704 · PMID 42147809

Europe PMC DOI

hedged sentences

0.0010

closest p · 0.0× alpha

0.0710

boldest claim

The sentences

highly significantp < 0.001actually significant

GALNT14 exhibited a highly significant upregulation in sepsis patients compared to controls ( p < 0.001) (Figure 4e ).

also in 132,142 other papers

did not reach statistical significancep = 0.071so close (0.05 < p ≤ 0.1)

Although the survival analysis for GALNT14 did not reach statistical significance ( p = 0.071) in the limited cohort available, the separation of survival curves shows a trend toward prognostic differentiation that warrants further validation in larger, independent cohorts (Figure 4c,f ). 3.5.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.